Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AVEONASDAQ:CHMANASDAQ:TCDANASDAQ:TFFPNASDAQ:TLC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVEOAVEO Pharmaceuticals$15.00$14.97$3.06▼$15.00$521.45M1601,442 shs247,800 shsCHMAChiasma$3.76$4.01$2.77▼$5.74$217.68M1.282.12 million shs147 shsTCDATricida$0.13$0.09▼$13.85$6.01M0.2217.62 million shs31.13 million shsTFFPTFF Pharmaceuticals$3.03+17.0%$6.17$2.51▼$21.25$7.62M1.2928,566 shs62,771 shsTLCTaiwan Liposome$7.00$7.10$4.07▼$7.70$294.54M0.99133,095 shs12,421 shsThese 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVEOAVEO Pharmaceuticals0.00%0.00%0.00%0.00%0.00%CHMAChiasma0.00%0.00%0.00%0.00%0.00%TCDATricida0.00%0.00%0.00%0.00%0.00%TFFPTFF Pharmaceuticals-17.04%-26.70%-66.45%-46.03%-84.20%TLCTaiwan Liposome0.00%0.00%0.00%0.00%0.00%top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVEOAVEO PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ACHMAChiasmaN/AN/AN/AN/AN/AN/AN/AN/ATCDATricidaN/AN/AN/AN/AN/AN/AN/AN/ATFFPTFF Pharmaceuticals1.3078 of 5 stars3.53.00.00.01.10.00.6TLCTaiwan LiposomeN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVEOAVEO PharmaceuticalsN/AN/AN/AN/ACHMAChiasmaN/AN/AN/AN/ATCDATricidaN/AN/AN/AN/ATFFPTFF Pharmaceuticals3.00Buy$72.002,280.17% UpsideTLCTaiwan LiposomeN/AN/AN/AN/ACurrent Analyst RatingsLatest TCDA, TFFP, CHMA, AVEO, and TLC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/28/2024TFFPTFF PharmaceuticalsRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$56.00 ➝ $44.00(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVEOAVEO Pharmaceuticals$42.29M12.33N/AN/A$1.33 per share11.28CHMAChiasma$1.11M196.11N/AN/A$1.59 per share2.36TCDATricidaN/AN/AN/AN/AN/AN/ATFFPTFF Pharmaceuticals$730K10.44N/AN/A$4.04 per share0.75TLCTaiwan Liposome$3.63M81.14N/AN/A$0.83 per share8.43Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVEOAVEO Pharmaceuticals-$53.34M-$0.84N/A28.85N/A-30.79%-81.66%-28.83%N/ACHMAChiasma-$74.78M-$1.43N/AN/AN/AN/A-113.57%-57.62%N/ATCDATricida-$176.57M-$2.36N/AN/AN/AN/AN/A-103.81%N/ATFFPTFF Pharmaceuticals-$21.24M-$12.51N/AN/AN/A-2,897.95%-163.14%-144.77%5/9/2024 (Estimated)TLCTaiwan Liposome-$35.02M-$0.88N/AN/AN/A-299.27%-120.45%-55.11%N/ALatest TCDA, TFFP, CHMA, AVEO, and TLC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/28/2024Q4 2023TFFPTFF Pharmaceuticals-$2.00-$2.01-$0.01-$2.01$0.20 million$0.11 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVEOAVEO PharmaceuticalsN/AN/AN/AN/AN/ACHMAChiasmaN/AN/AN/AN/AN/ATCDATricidaN/AN/AN/AN/AN/ATFFPTFF PharmaceuticalsN/AN/AN/AN/AN/ATLCTaiwan LiposomeN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVEOAVEO Pharmaceuticals0.942.372.35CHMAChiasmaN/A7.917.08TCDATricidaN/A4.874.87TFFPTFF PharmaceuticalsN/A3.123.12TLCTaiwan Liposome0.673.013.01OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVEOAVEO Pharmaceuticals49.95%CHMAChiasma61.68%TCDATricidaN/ATFFPTFF Pharmaceuticals15.25%TLCTaiwan Liposome0.22%Insider OwnershipCompanyInsider OwnershipAVEOAVEO Pharmaceuticals3.29%CHMAChiasma8.30%TCDATricida35.60%TFFPTFF Pharmaceuticals5.60%TLCTaiwan LiposomeN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAVEOAVEO Pharmaceuticals11434.76 million33.62 millionOptionableCHMAChiasma8557.89 millionN/ANot OptionableTCDATricida5755.67 million35.85 millionNot OptionableTFFPTFF Pharmaceuticals192.52 million2.38 millionOptionableTLCTaiwan Liposome2,02042.08 millionN/ANot OptionableTCDA, TFFP, CHMA, AVEO, and TLC HeadlinesSourceHeadlineHow to watch TLC’s ‘Little People, Big World’ new episodes free April 23masslive.com - April 23 at 6:13 PMWhy Kody Brown is the Most Disliked TLC Villain of All Timeyahoo.com - April 21 at 12:36 PM'I end up pooping myself on stage,' man cries after botched weight loss surgery in new TLC showmsn.com - April 19 at 10:23 AM‘7 Little Johnstons’ Season 14: How to watch episode 6 on TLC for freemsn.com - April 16 at 7:23 PMMonday: ‘Seeking Sister Wife’ Season 5, episode 7: How to watch TLC online for freecleveland.com - April 15 at 7:49 PMSee inside three-bed end terrace on sale for just £35k, but it needs serious TLCmsn.com - April 15 at 9:47 AMThe Disco Biscuits Nod To OutKast, TLC, Gucci Mane, & More In Atlanta [Video/Audio]liveforlivemusic.com - April 14 at 6:18 PMRico Wade, legendary Atlanta producer who worked with OutKast and co-wrote TLC's 'Waterfalls,' dies at 52msn.com - April 13 at 8:27 PMRico Wade, TLC ‘Waterfalls’ Cowriter and Southern Rap Trailblazer, Dies at 52thewrap.com - April 13 at 3:27 PMMorris continues new Brooks-TLC pleaobservertoday.com - April 12 at 8:34 AMTLC starts $27m upgradeaustralianageingagenda.com.au - April 11 at 8:17 PMTLC donates to Clatsop Animal Assistancedailyastorian.com - April 11 at 10:16 AMTLC Should Cancel ‘Sister Wives’ After Garrison Brown’s Suicidemsn.com - April 10 at 6:46 PMHow to watch TLC’s ‘Take My Tumor’ season 1, episode 2, stream for freepennlive.com - April 10 at 1:45 PMCrimestoppers seek tips on $500+ equipment theft from TLC Tree Service in Pananewschannel20.com - April 9 at 3:11 PM‘Seeking Sister Wife’ Season 5, episode 6: How to watch TLC online for freecleveland.com - April 8 at 7:40 PMHow to watch TLC’s ‘Seeking Sister Wife’ new episode free Monday, April 8masslive.com - April 8 at 7:40 PM'OutDaughtered' and 'Doubling Down With the Derricos' Finally Returning to TLC—See the Exclusive Teasersmsn.com - April 8 at 2:39 PMTLC is coming to the 2024 Wisconsin State Fair, with Jordin Sparks opening the concertmsn.com - April 8 at 2:39 PMFans Rejoice as ‘OutDaughtered’ and ‘Doubling Down With the Derricos’ Set to Premiere New Seasons on TLCmsn.com - April 8 at 2:39 PM2024 Wisconsin State Fair: TLC takes Main Stageyahoo.com - April 8 at 9:39 AM2024 Wisconsin State Fair: TLC takes Main Stage, Aug. 2fox6now.com - April 8 at 9:39 AMGoonya Fighter: First-Aid Boxes and some TLCkotaku.com - April 7 at 8:14 AMEastern Carolina woman looking for love on new season of TLC showwitn.com - April 6 at 10:36 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAVEO PharmaceuticalsNASDAQ:AVEOAVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.ChiasmaNASDAQ:CHMAChiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.TricidaNASDAQ:TCDATricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.TFF PharmaceuticalsNASDAQ:TFFPTFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as Augmenta monoclonal antibodies for the treatment of COVID-19 therapeutics; TFF Niclosamide, which is completed Phase 1 clinical trials for the treatment of COVID-19 disease; and other vaccines. TFF Pharmaceuticals, Inc. has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop Augmenta monoclonal antibodies; a licensing and collaboration agreement with UNION therapeutics A/S; and a collaborative research and development agreement with the National Institute of Environmental Health Sciences to develop dry powder formulations of hyaluronan to prevent and treat respiratory diseases. The company was incorporated in 2018 and is headquartered in Fort Worth, Texas.Taiwan LiposomeNASDAQ:TLCTaiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.